3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Turcot syndrome
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Cancer Patients
1
Interventions
pembrolizumab
3
sintilimab
1
XELOX
1
Surgical Procedures, Operative
1
Nivolumab
1
Megestrol Acetate
1
Medroxyprogesterone Acetate
1
Ipilimumab
1
Induction Chemotherapy
1
Immunotherapy
1
DNA Mismatch Repair
1
DEAE-Dextran
1
Colonoscopy
1
Chemotherapy, Adjuvant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Turcot syndrome
×
DEAE-Dextran
×
Clear all
NCT07403877
2026-02-11
TORCH-OPTIMA
Fudan University
Phase 2
Not yet recruiting
114 enrolled